Life Sciences and Pharma

Creative That Survives Review

Life sciences is the only industry where a headline needs a reference list. Medical-legal review will strip anything it can't substantiate, which is why so much pharma creative arrives at market sanded down to nothing. The craft isn't fighting review — it's designing for it. Concepts built on claims the data actually supports don't die in committee, and messages engineered around the approved language from the start keep their spine through every revision cycle.

The same discipline applies to the audiences. Clinicians give promotional material seconds, not minutes, and they extend those seconds only to work that respects their intelligence. Patients need empathy that doesn't slide into promise. Both can tell when creative was made by people who did the reading.

What We Bring, Plainly

We are a creative and strategy partner, not a regulatory consultancy — your medical and legal teams own the rulebook, and we build work that performs inside it. Where we add the most: translating mechanism-of-action complexity into materials humans can follow, building launch narratives that hold together from HCP deck to patient site, and bringing consumer-grade craft to a category that too often accepts less because the rules are hard.